✦ LIBER ✦

Phase II study of recombinant human interleukin 3 administration following carboplatin and etoposide chemotherapy in small-cell lung cancer patients

✍ Scribed by S. Kudoh; Toshiyuki Sawa; Naotsugu Kurihara; Kiyoyuki Furuse; Yuzo Kurita; Masahiro Fukuoka; Minoru Takada; Fumimaro Takaku; Makoto Ogawa; Yutaka Ariyoshi

Publisher: Springer
Year: 1996
Tongue: English
Weight: 138 KB
Volume: 38
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s002800051046

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of combination chemothera

Phase II trial of combination chemotherapy with cisplatin, carboplatin and etoposide in stage IIIB and IV small-cell lung cancer

✍ Yoichi Nakanishi; Yuji Kawarada; Nobuyuki Hirose; Kiyoshi Ninomiya; Masayuki Miy 📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 340 KB

Phase II study of intensive chemotherapy

Phase II study of intensive chemotherapy with carboplatin, ifosfamide and etoposide plus recombinant human granulocyte colony-stimulating factor and sequential radiotherapy in locally advanced, unresectable non-small-cell lung cancer

✍ Giorgio Vittorio Scagliotti; Umberto Ricardi; Lucio Crinó; Ernesto Maranzano; Fi 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 375 KB

Phase II study of gemcitabine and carbop

Phase II study of gemcitabine and carboplatin in patients with advanced non-small-cell lung cancer

✍ Lin Run Wang; Ming Zhu Huang; Guo Bing Zhang; Nong Xu; Xiu Hua Wu 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 385 KB

A phase II study of carboplatin and vinc

A phase II study of carboplatin and vincristine in previously treated patients with small-cell lung cancer

✍ Egbert F. Smit; Henk H. Berendsen; Elisabeth G. E. Vries; Nanno H. Mulder; Piete 📂 Article 📅 1989 🏛 Springer 🌐 English ⚖ 340 KB

Alternating weekly administration of pac

Alternating weekly administration of paclitaxel and gemcitabine: a phase II study in patients with advanced non-small-cell lung cancer

✍ David Aguiar; José Aguiar; Uriel Bohn 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 207 KB

Phase II study of carboplatin and gemcit

Phase II study of carboplatin and gemcitabine as adjuvant chemotherapy in patients with completely resected non-small cell lung cancer: a report from the Central Japan Lung Study Group, CJLSG 0503 trial

✍ Noriyasu Usami; Kohei Yokoi; Yoshinori Hasegawa; Hiroyuki Taniguchi; Joe Shindo; 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 158 KB